Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma

Helzinger, 1999, Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma, Ann Oncol, 10, S122, 10.1093/annonc/10.suppl_4.S122

Terada, 1998, c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma, Histopathology, 33, 325, 10.1046/j.1365-2559.1998.00496.x

Kawaki, 2000, Allelic loss in human intrahepatic cholangiocarcinoma: correlation between chromosome 8p22 and tumor progression, Int J Cancer, 88, 228, 10.1002/1097-0215(20001015)88:2<228::AID-IJC13>3.0.CO;2-8

Kim, 2001, Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding, Genes Chromosomes Cancer, 30, 48, 10.1002/1098-2264(2000)9999:9999<::AID-GCC1053>3.0.CO;2-P

Storto, 1990, Chromosomal breakpoints in cholangiocarcinoma cell lines, Genes Chromosomes Cancer, 2, 300, 10.1002/gcc.2870020408

Wong, 1999, Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis, Am J Pathol, 154, 37, 10.1016/S0002-9440(10)65248-0

Wong, 2000, A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping, Hepatology, 32, 1060, 10.1053/jhep.2000.19349

Shiraishi, 2001, A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas, Oncology, 60, 151, 10.1159/000055313

Kang, 2000, Allelotype analysis of intrahepatic cholangiocarcinoma, Mod Pathol, 13, 627, 10.1038/modpathol.3880108

Marchio, 1997, Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization, Genes Chromosomes Cancer, 18, 59, 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0

Shiraishi, 1999, Genetic aberrations detected comparative genomic hybridization in biliary tract cancers, Oncology, 57, 42, 10.1159/000011999

Dalbagni, 1993, Genetic alterations in bladder cancer, Lancet, 342, 469, 10.1016/0140-6736(93)91595-D

Burbee, 2001, Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression, J Natl Cancer Inst, 93, 691, 10.1093/jnci/93.9.691

Dammann, 2001, Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers, Cancer Res, 61, 3105